NAPROSYNE 250 mg, tablet 10 tablets, CIP 3400931684381
Active ingredients: Naproxen
Commercialized according to BDPMDispensing in France: Prescription only
Tablet10 tablets, CIP 3400931684381orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NAPROSYNE 250 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- 10 plaquette(s) poly(chlorure-acétochlorure) de vinyle aluminium de 1 comprimé(s)
- Marketing authorisation holder
- LABORATOIRES GRUNENTHAL
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 5 Mar 2026
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69378155CIP73168438CIP133400931684381Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NAPROXÈNEcomprimé | 250,00 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.